Chime General Counsel Adam Frankel Sells 3,000 Shares Amid Broader Market Decline.

Frankel’s June 15 sale was for a total of $52,500 (3,000 shares at an average $17.50), and the transaction was disclosed as a 0.98% decrease in his holdings. After the sale, his remaining stake was valued at about $5.316 million.
On the trading day after the sale, CHYM fell by $0.59 to $17.05, with 3,826,734 shares traded versus an average volume of 4,262,830—information that provides context for immediate market reaction alongside the insider transaction.
The Cerbat Gem report also places CHYM in specific valuation/price context at the time: a price-to-earnings ratio of -2.29, a 50-day moving average of $19.52, a 200-day moving average of $21.89, and a 52-week range of $15.88 to $38.67.
The StockTitan excerpt of the Form 4/SEC disclosure notes the sale as “3,000 shares of Class A Common Stock at $17.50 per share” and includes language that some of the securities involved were “restricted stock units (‘RSUs’).” That matters because RSU vesting/sale can affect the supply of shares and insider disposition patterns.
Analyst sentiment was also referenced: UBS Group increased its price objective on Chime from $24.00 to $27.00 and reiterated a “neutral” rating in a Feb. 26 research note—additional context beyond the insider sale and company financials.
Chime Financial General Counsel Adam Frankel sold 3,000 shares of Class A Common Stock on June 15, 2026, at $17.50 per share, collecting $52,500 in the open market, according to GuruFocus. The sale trimmed his stake by just 0.98%, leaving him with 303,795 shares worth roughly $5.3 million — a signal of routine diversification rather than a dramatic exit.
The move landed at a rough moment for the stock. The day after the sale, CHYM dropped $0.59 to close at $17.05, per Investing.com. That price sits well below both the 50-day moving average of $19.52 and the 200-day moving average of $21.89 — and about 37% under Chime's June 2025 IPO price of $27.00.
This was not Frankel's first sale of the month. Just six days earlier, on June 9, he sold another 3,000 shares at $18.00, according to Investing.com. Together, the two transactions total 6,000 shares and roughly $106,500 in proceeds. Over the past 12 months, insider data tracked by GuruFocus shows 13 sells and zero buys from Chime insiders — a consistent pattern of gradual offloading with no new accumulation.
The SEC Form 4 filing noted that some of the securities involved were Restricted Stock Units, or RSUs. RSUs vest over time and are often sold right away to cover tax bills. That detail matters. It means Frankel's sales may be pre-planned tax events — not a discretionary bet against the company's future, according to Stock Titan.
The insider sales come on the heels of a major milestone. In May, Chime reported Q1 2026 earnings per share of $0.13 — its first-ever quarter of GAAP profitability, and well above analyst expectations of -$0.08, per Investing.com. Revenue grew 30.69% in 2025, reaching $2.19 billion annually. Despite that progress, the stock's price-to-earnings ratio still sits at a negative figure, reflecting the company's longer history of losses.
CEO Chris Britt has set a revenue target of $2.7 billion for the current fiscal year, per GuruFocus. The next big test comes August 6, 2026, when Chime reports Q2 earnings. If the company posts a second straight profitable quarter, insider sales like Frankel's will likely draw far less scrutiny.
Wall Street is not in agreement on CHYM. Goldman Sachs analyst Will Nance carries a "Buy" rating with a $30.00 price target, calling Chime's profitability pivot a "significant milestone," per GuruFocus. Piper Sandler holds an "Overweight" rating but cut its target from $35.00 to $30.00 earlier this year. UBS, meanwhile, raised its target from $24.00 to $27.00 in February but kept a "Neutral" rating.
The stock's 52-week range tells the full story of volatility: a low of $15.88 and a high of $38.67, per Investing.com. That $22 spread reflects a company still searching for a stable floor after its splashy IPO debut. With Frankel still holding over 300,000 shares, his skin in the game remains substantial — even after two weeks of selling.
Frankel is not the only one reducing exposure. Maltese Capital Management LLC cut its Chime stake by 12.9% in the fourth quarter, selling 54,549 shares and leaving it with 368,263 shares, according to Ticker Report. Institutional trimming alongside insider sales can amplify downward price pressure, especially when trading volume — 3.83 million shares on June 16 — runs below the 4.26 million daily average.
Publishers
17
Articles
16
Reach
33